DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

58.52 -0.35 (-0.59%)

REAL-TIME: Last trade at

Extended Hours: $58.52 $0.00 (0.00%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

BMY $58.52 -0.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.82
Previous Close $58.87
Daily Range $58.09 - $58.86
52-Week Range $46.30 - $59.50
Market Cap $97.1B
P/E Ratio 36.34
Dividend (Yield) $1.44 (2.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,515,312
Average Daily Volume 7,715,481
Current FY EPS $1.79





Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

Why These Big Pharma Stocks Could Plunge Next Year

We asked three of our top healthcare analysts which big pharma stocks could face tough times in 2015. Here is what they had to say.

Another Cancer Drug Deal, It’s Bristol-Myers Squibb This Time

Celgene's PDE4 Inhibitor Otezla Gets Positive CHMP Opinion - Analyst Blog

Novo Nordisk's Victoza Recommended for Label Expansion - Analyst Blog

A Buy Recommendation From Absolute Valuation Model to Bristol-Myers Squibb

Weekly Pharmaceutical Notes: Pfizer, Johnson & Johnson, Bristol-Myers Squibb And Roche

Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen

J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog

Roche’s Avastin Gets Approval For Ovarian Cancer, But Incremental Revenues Will Be Small

Will Bristol-Myers Squibb's Dividend Be Safe?

Bristol-Myers Squibb is battling patent expiration, but some fast-growing new drugs just may be able to save its dividend.

See More BMY News...

BMY's Top Competitors

BMY $58.52 (-0.59%)
Current stock: BMY
JNJ $106.70 (-0.17%)
Current stock: JNJ
PFE $30.47 (0.83%)
Current stock: PFE
RHHBY $37.21 (-0.37%)
Current stock: RHHBY